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ABSTRACT 
Thirty-two heptapeptides have been synthesized and characterised to establish the effect of LysàAsp 
(iài+4) lactamisation upon their ability to adopt a helical conformation. Since most parallel and 
dimeric coiled coil sequences can be deconvoluted into gabcdef repeats, we have introduced fixed 
solvent exposed bàf (KàD) constraints into this design scaffold. Interfacial ‘a’ hydrophobic (L/I/V/N) 
and ‘e/g’ electrostatic (E/K) options (4 x 2 x 2 = 16 cassettes) were introduced as core drivers of coiled 
coil stability and specificity. All present as random coil when linear but adopt a helical conformation 
upon lactamisation. Helicity varied in magnitude from 34% to 68%, indicating different levels of 
constraint tolerance within the context of a sequence required to be helical for function. Using the 
oncogenic transcription factor cJun as an exemplar, we next utilised our bCIPA coiled coil screening 
engine to select four cassettes of highest predicted affinity when paired with four gabcdef cassettes 
within the full-length cJun target counterpart (164 = 65,536 combinations). This information was 
coupled with observed helicity for each constrained cassette to select for the best balance of predicted 
affinity when linear and experimentally validated helicity when constrained. As a control, the same 
approach was taken using cassettes of high predicted target affinity, but with lower experimentally 
validated helicity. The approach provides a novel platform of modular heptapeptide cassettes 
experimentally validated and separated by helical content. Appropriate cassettes can be selected and 
conjugated to produce longer peptides in which constraints impart appropriate helicity such that a 
wide range of targets can be engaged with high affinity and selectivity.   
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INTRODUCTION 
It is very difficult to establish if a given peptide sequence will tolerate a helix inducing 
constraint, meaning that their introduction into peptide sequences towards the goal of imparting 
helicity, and ultimately increased target affinity, is largely a trial-and-error process1. However, it has 
long been known that peptides of less than 15 residues (1-4 helical turns) are unable to independently 
form thermodynamically stable α-helices in water2. Longer helices form due to a sequential 
development of intra-strand hydrogen bonds, propagating from a N-terminal folding nucleus towards 
the C-terminus3. This process is interrupted within short synthetic sequences as water molecules 
compete with the C=O:H-N interactions of the peptide backbone, meaning that the formation of the 
helix becomes energetically less favourable since the entropic cost associated with folding increases4. 
Helical stabilisation of shorter peptides is therefore an area of intense interest, particularly in protein-
protein interactions where biological activity is mediated by helicity5. Multiple methods to modify 
peptides to increase their stability have been explored, including hydrogen bond surrogates6,7, triazole 
linkers8, hydrocarbon staples4, double-click linkers9,10, lactam bridges2,9–12, and other techniques based 
on macrocyclisation chemistries.9,10  
Of all helix-inducing constraints currently available, lactamisation is a particularly powerful 
approach to increasing the stability of short helical peptides. It is an example of side-chain stapling, in 
which, for example, a peptide bond can be formed between Lys and Asp residues. By coupling amine 
and carboxylate containing side chains at residues spaced 4 residues apart (i-i+4 configuration) the 
constraint is able to function such as to complement that of the hydrogen bonds found in native α-
helices4,5,9,13. Although successful lactamisation of small peptides has been observed11,14–17 there is still 
a lack of comparative data on tolerance with respect to longer peptide sequences, and consequent 
designs that can be implemented towards practical usage. Our group have adopted a strategy of KàD 
lactamisation, since this has been shown to be the most potent inducer of  α-helicity in short peptide 
sequences relative to alternative approaches2 . 
Here we describe a technique that combines computational design18–22 with single heptad 
lactamisation to form stable and functional coiled coil peptides. We are primarily focused on the 
comparison of iài+4 (KàD) lactamisation tolerance within individual heptad cassettes corresponding 
to coiled coil sequences. This is towards a major goal of increasing helicity conferred upon parental 
sequences in which heptad repeats are contained, thus avoiding a trial and error search for constraints 
that will be tolerated or that, more importantly, will impart helicity. We are additionally interested in 
combining the most promising lactamised heptads to form longer peptides in which they are 
tolerated. Previous studies of helicity imposed by lactamisation of pentapeptides have shown that this 
has the potential to be used as a generalised approach12. We have previously demonstrated the bZIP 
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Coiled coil Interaction Prediction Algorithm (bCIPA) to be a valuable tool in the design of peptides that 
can antagonise coiled coil interactions involved in the formation of basic leucine zippers (bZIPs)18,21,22. 
Here we describe the combination of computational and experimental techniques towards 
investigating the ability to generate helically constrained heptads. These are then applied towards the 
larger goal of designing longer constrained α-helices in which the likelihood of achieving increased 
helicity and more importantly, improved binding, is increased. As a proof of concept, we explore the 
ability of modular heptapeptide cassettes that are capable of interfering with the native cJun coiled 
coil, relative to a counterpart that despite computational selection, contains heptapeptide modules 
that are found to constrain poorly. Specifically, we seek to address: i) does lactamisation promote 
helicity in heptapeptide cassette sequences?  ii) does the helicity imparted in any given cassette vary 
according to the sequence? iii) are cassettes are able to be conjugated into longer sequences while 
retaining/improving helicity relative to linear counterparts? iv)  Using an exemplar target, can such 
sequences be used to promote increased target-affinity relative to their linear counterparts? 
 
 
 
RESULTS AND DISCUSSION 
There are a range of methodologies for constraining short peptides into helical structures, but the 
most potent inducer of helicity for short sequences has been shown to be KàD (iài+4) 
lactamisation15,23. Lactamisation has the added benefit of introducing a very discreet change to the 
linear peptide sequence; the constraint consists simply of a condensation reaction between two 
naturally occurring side chain sequences, resulting in the formation of a peptide bond. Despite this, 
for a given sequence it can be very difficult to predict if a lactam bridge will be tolerated, meaning that 
the process of introducing lactam bridges to impart increased helicity upon is trial and error. Here we 
describe the first use of an approach that seeks to synthesize and characterise modular cassettes with 
a wide range of sequence-specific properties that are desired for coiled coil forming interactions, such 
that they can be sorted into i) those of experimentally validated high helicity and ii) those predicted 
to bind to an oncongenic coiled coil target sequence. The study provides the first set of modular 
cassettes that can serve such a purpose, with a view to being able to select the most appropriate 
balance of helicity and target affinity, such that cassettes can be conjugated towards targeting the 
cJun coiled coil target. 
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Heptad Library Design – We have created a peptide library consisting of seven residue sequences that 
correspond to one heptad repeat of a coiled coil motif (gabcde; gaKALeD). In this library, positions g 
and e positions, which are important in forming electrostatic contacts within a coiled coil sequence24,25 
were randomised to generate E/K options, with a view to generating potential attractive and repulsive 
options with the corresponding positions of the target. Similarly, the a position corresponding to the 
core region within a coiled coil sequence was randomised to generate L/I/V/N options. The c and d 
positions were fixed as A and L respectively, to impart helicity and further core hydrophobicity that is 
characteristic of the parallel dimeric coiled coil motif26. Each peptide was next synthesized in both 
linear and lactamised form (bàf; KàD), to probe for constraint tolerance and helical induction (Figure 
1). The options for each cassette therefore provided a library of 16 constrained (g/a/e options; 2 x 4 x 
2 = 16) and 16 linear heptapeptides with diverse electrostatic and hydrophobic characteristics. The 
options were provided to create a series of modular peptides, generating the required electrostatic 
and hydrophobic contributions to binding with any heptad counterpart within a defined target helix. 
In particular, by confining electrostatic interactions between peptide and target (i.e. gi – ei’+1) to the 
same gabcdef repeat, interactions could be calculated completely independently during prediction 
and therefore each cassette considered truly modular. The final two solvent exposed positions (b and 
f; iài+4 spacing) were chosen as the most appropriate positions to constrain within each modular 
cassette while avoiding potential interference with the binding interface.  
 
Individual Cassette Helicity Measurements – Having synthesized all sixteen peptides as both linear 
and constrained cassettes (see Figure S1-S4 for mass spectrometry data) it was next sought to 
establish the extent to which each adopted a helical conformation upon introduction of the lactam 
constraint (Figure 2). As expected, all sixteen sequences adopted a random coil confirmation in the 
absence of a lactam constraint, with one characteristic minimum at ~190 nm. In contrast, all sixteen 
cassettes adopted an α-helical conformation upon introduction of the KàD constraint, with 
characteristic minima at 208 and 222 nm. However, the extent to which each of the sixteen 
constrained cassettes adopted a helical conformation varied widely, with values ranging from 34 % to 
68 % helicity (eq 1). The helicity of peptides in both linear and constrained format were next studied 
to establish the fractional helicity (fH) gained in constrained form (Figure 3). In doing so it was found 
that no cassette in linear form exceeded 19% fH based on the raw 222 nm signal (Figure S5, Table 1), 
whereas even the lowest lactamised peptide was 34% helical, while displaying a characteristic α-
helical signature (Table 1, Figure 3, Figure S6). As all cassettes exhibited helicity at 20°C when 
lactamised, with further thermal scans undertaken to monitor the stability of the cassettes at 10°C 
increments. At the final scan of 90°C, although loss of stability for all lactamised cassettes was 
observed, all 16 presented an α -helical signature with an average of 38% helicity, indicating that 
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helicity is maintained at higher temperatures where no structure would be expected for any linear 
counterpart. Constrained peptides displayed characteristic 222/208 minima, and consistent with 
lactamisation no cooperative unfolding profile was observed. Moreover, after heating to 90°C each 
cassette returned to within 5% of the original signal when incubated at 20°C (Figure S6), indicating 
that any loss of structure is fully reversible.  
 
Predicting the Stability of Cassettes with Heptads within cJun – To provide further evidence for the 
validity of our approach, in parallel to measuring individual cassette helicities, we used bCIPA to screen 
each of the sixteen sequences against individual gabcdef heptads within a cJun coiled coil target 
sequence. This was performed to provide a qualitative ranking of the most appropriate cassette to 
take forward when only considered as a linear heptad. bCIPA prediction is a useful as a tool to gain 
understanding of the most appropriate core and electrostatic options required for target stability, as 
well as for specificity of interaction, for instance in avoiding homodimerization over target 
interaction20–22. Hence, bCIPA aids in selecting which cassettes are most appropriate for conjugation 
in targeting a coiled coil sequence (i.e which are predicted to bind and adopt a conformation of high 
helicity). These can then be taken forward for each given heptad within a target sequence. Since bCIPA 
is trained and validated on longer coiled coil sequences, the values generated are purely qualitative 
and are not treated as true Tm values. As shown in Table 2, the bCIPA values generated have been 
normalised to serve alongside helicity in predicting the most appropriate balance of helicity and 
affinity for each heptad within the target. 
 
Combinational Design to Target cJun – Two four-heptad peptides were created to target the coiled 
coil region of the oncogenic transcriptional regulator protein cJun. Using this approach, cassettes were 
selected that when conjugated in linear form that were predicted to bind with high affinity to the cJun 
target sequence (Figure 4). In particular, two peptides were tested; one was predicted to contain 
cassettes that constrain poorly and therefore impart poor helicity upon the full-length peptide 
sequences (peptide 6-2-13-5; individual cassette fH values = 36%, 34%, 47%, and 41% respectively – 
Table 2 highlighted in yellow), and a second peptide that was predicted to contain cassettes which 
constrain well and impart high levels of helicity upon the full-length peptide sequence (peptide 1-3-
16-17; individual cassette fH values = 45%, 60%, 55%, and 68% respectively – Table  2 highlighted in 
green). Both peptides were selected by using a combination of i) normalised bCIPA values and ii) the 
fH of the lactamised cassettes (Table 2). Having calculated fH for all 16 lactamised cassettes, each were 
next individually screened against the first four heptads of cJun. This permitted selection from 164 
(65,536) possible unique cassette arrangements to predict the most appropriate sequence for 
effective binding. Combining cassettes 1, 3, 16, and 7 (Figure 4) led to the design of a constrained 
 6 
peptide predicted to form both a stable α-helix (average cassette helicity = 57%) but with the 
additional possibility of forming a higher affinity coiled coil with the target cJun, relative to the linear 
counterpart (linear 1-3-16-7:cJun bCIPA predicted Tm = 38°C). As a control, cassettes were also 
conjugated which were similarly highly ranked according to the bCIPA screening process. However, in 
contrast, these sequences were experimentally validated to be of low isolated helicity (average helicity 
= 39%, linear 6-2-13-5:cJun bCIPA predicted Tm = 41°C). This resulted in a combination of cassettes 
6,2,13, and 5 (Figure 4). This permitted the comparison of two sequences, both of which were 
predicted to engage with the target as linear 28mers (Figure 4). Computationally, both peptides score 
very highly, with 6-2-13-5 computationally ranked as #145 and 1-3-16-7 as #450 – both within the top 
1% of the library of full length peptides. Indeed, both sequences contain the same net favourable 
electrostatic contribution (see below), and comparable core contributions, as well as Asn residues at 
position a3 to promote asymmetric side chain-side chain hydrogen bonding with the corresponding 
Asn in the cJun partner strand26,27. However, while 1-3-16-7 was expected to lactamase well and 
translate into improved binding, 6-2-13-5 was expected to lactamase poorly leading to a lower gain of 
coiled coil stability. During the design process eight unique cassettes were selected to avoid 
duplication of any modules, and to widen the potential understanding of each cassette use in 
combination. Both sequences 1-3-16-7 (YEIKALED-ELKALED-KNKALKD-EIKALKD) and 6-2-13-
5 (YKVKALED-KIKALED-ENKALED-EVKALED) were synthesized with a Tyr at the N-terminus for 
quantification by UV absorbance. Both sequences terminate at the f position of the 4th heptad (Figure 
4), and contained two lactam bridges – one at either termini. As helicity is thought to propagate from 
the N-terminus to the C-terminus3, stabilisation via heptads 1 and 4 was predicted to promote overall 
helicity towards heptads 2 and 3 at the helix interior. In contrast to previous work18,21,22,28, the 29-mers 
were not capped with helicity promoting residues (AS at N-terminus and GAP at the C-terminus) to 
further probe the effect of lactamisation in directly promoting helicity. 
Upon inspection of the helical wheels (Figure 4), a pattern of electrostatically favourable and 
unfavourable interactions was observed. As selected by bCIPA, as a potential homodimer peptide 1-
3-16-7 displayed 6 repulsive electrostatic interactions (4 Glu-Glu and 2 Lys-Lys) and only 2 attractive 
interactions (2 Glu-Lys). In the 6-2-13-5 control, 4 repulsive and 4 attractive interactions are present. 
As potential heterodimers with cJun, both peptides contain 4 favourable and one unfavourable 
interaction.  As discussed previously22, cJun contains Gln and Ala at the g3 and e3 positions. The a3-
a3’ was chosen to generate an Asn-Asn interaction for both sequences, due to the favourable effect 
of this interaction on specificity and on the oligomeric state.  
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Structural Stability of Terminally Lactamised Peptides - An analysis of the global secondary structure 
of the full-length linear and lactamised peptides was conducted, both in isolation and in complex with 
with cJun. CD spectra showed 1-3-16-7 to display high levels of helicity in both linear (65.3%) and 
lactamised (71.4%) forms (Figure 5a). At 20°C, the stability of the two are comparable (ΔfH = 6.1%), 
with the lactamised version displaying an improved helical signature (222/208 ratio = 1.01). In contrast 
the linear 6-2-13-5 peptide displays comparatively low helicity (Figure 5b, fH = 18.2%), increasing upon 
lactamisation to display an improved overall α-helical signature (222/208 = 0.69) but  with little change 
in overall helicity (fH = 20.4%). 
Global secondary structure and stability was next monitored by incubating peptides with cJun. 
At 20°C the linear form of 1-3-16-7 (Figure 6a) showed a helical profile (222/208 = 0.87) with a 
fractional helicity greater than the average (fH = 55.2%) of the component peptides (ΔfH = 8%). For 
the lactamised version (Figure 6b), the profile remained highly helical (222/208 = 0.90) with helicity 
(fH = 52.0%) negligibly greater than the average of the two component peptides (ΔfH = 1.75%). In both 
the linear and lactamised forms of 6-2-13-5 (Figure 7a,b), levels of helicity were lower. The linear form 
incubated with cJun displayed no increase in signal (ΔfH = 0.1%) relative to the component peptides. 
Similarly, the lactamised form showed a level of helicity (fH = 25%) similar to that of the average.  
 
Thermal Denaturation Profiles - Having observed varying levels of helicity between all peptides, CD 
thermal denaturation experiments were next performed to establish the extent to which the stability 
of the complexes changed upon introduction of the constraints. In these experiments the 222 nm 
signal was monitored at 1°C increments from 0°C to 90°C. For linear 1-3-16-7 in isolation (Figure 5C), 
an interaction was observed (Tm = 29.1°C), which upon lactamisation led to an increase in thermal 
stability (Tm = 67.0°C). Moreover, the signal persisted even at high temperatures, implying that the 
lactamised form retains residual thermal stability relative to the linear form. When in complex with 
cJun (Figure 6C,D), the linear peptide exhibited an increase in Tm (34°C), with the lactamised form 
displaying a marked increase in thermal stability over the average of the component peptides, 
demonstrating that the lactamised form of the peptide is able to preferentially bind cJun. The DTm (1-
3-16-7LAC:cJun — 1-3-16-7LIN:cJun) was found to be 23°C, demonstrating that dual lactamisation is 
tolerated and translates into increase target affinity. 
For 6-2-13-15, both peptides displayed lower levels of stability (Figure 7C,D), with Tm values 
unable to be derived from the thermal melt profiles. Consistent with CD spectra, this implies a much 
lower level of thermal stability in isolation. However, upon incubation with cJun, the linear form 
displays higher levels of heterodimeric thermal stability (Tm = 18.9°C), which is increased upon 
lactamisation (Tm = 29.2°C). The DTm (6-2-13-5LAC:cJun — 6-2-13-5LIN:cJun) was found to be 10°C. 
Overall this suggests that, as reflected in the lower levels of helicity relative to 1-3-16-7LAC:cJun  (fH = 
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25 % vs 52%), the constraint is less well tolerated. Moreover, this consequently translates into a lower 
overall improvement in target affinity relative to the linear counterpart. Figure 8 highlights the 
relevance of these modular designs in the wider scheme of engineered peptides that can tolerate 
constraints and that lead to a demonstrable increase in target affinity for a defined coiled coil target.  
As previously discussed22, there are indirect parallels which can be drawn based on Tm. Previous 
isothermal calorimetry work characterising the biophysical properties of peptides demonstrated a 
FosW-cJun interaction KD value of 39 nM29,which displayed a thermal stability similar to that of the 
lactamised 1-3-16-7 (Tm = 63°C). Similarly, the 1-3-16-7LAC:cJun complex reported the same helicity (fH 
= 52%) and a similar Tm and KD to that of cFos-24 (Tm = 58°C; KD of 7.25  µM )30. The comparative values 
provide a broad understanding of enhanced structural stability displayed in lactamised complexes and 
demonstrate the potential impact lactamisation may have on biophysical properties, and the ability 
to predict such properties based upon modular design and experimental validation. 
 
Helix Nucleation - The folding of the α-helix is due in large part to the stabilisation conferred by 
sequential i-i+4 hydrogen bonds. Moreover, α-helices display an overall dipole moment with a pair of 
terminal micro-dipoles due to a lack of intrahelical hydrogen bonds at the termini. In particular, 
unsatisfied hydrogen bonding by the first four >N-H groups at the N-terminus can lead to a partial 
positive charge (d+). Similarly the last four >C=O groups at the C-terminus can lead to a partial negative 
charge (d-)31. Instead, these groups are often capped by alternative hydrogen bond partners that are 
provided by helix-capping motifs32. It is therefore generally accepted that charge-macrodipole 
interactions can play a small role in enhancing the stability of a helix – with negatively charged residues 
at the N-terminus and positively charged residues at the C-terminus that can counter the effects of 
the dipole. As highlighted in Figure 4, the designs of our full length α-helix could be optimised to 
counter the dipole. For peptide 1-3-16-7 Glu was introduced at the N-terminus and Lys at the C-
Terminus. However, the control peptide (6-2-13-5) did not provide charge complementarity for the 
helix macrodipole, containing a Lys at the N-terminus and Glu at the C-terminus. The former peptide 
is more stable than the latter (either as a homomer or in complex with cJun). Coupled with constraints 
that are less well tolerated in individual cassettes for the control sequence (average helicity of 
component cassettes = 57% vs 38%), this suggests that charge stabilisation at both termini, even with 
addition of less-well tolerated constraints, could be another influencing factor. Coupling the structural 
stability lactam bridges confer with favourable terminal residues may therefore represent another 
way to introduce additional target-affinity into the peptide.   
 
Sequence specific Helicities – Due to the limited randomisation and size of the cassette library, there 
exists an opportunity to further study the effects of the different sequence combinations from the 
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perspective of helical stability. Despite focusing on peptides longer than 10 residues, the idea of 
sequence specific stability (in the context of positions g/e) has been discussed previously20. The 
presence of N-terminal Glu and C-terminal Lys might have been expected to lead to the highest helicity 
values with every different core option. As is shown in Figure 9, there does appear to be a pattern 
within the library. For each of the 4 core options, it would be expected that the Glu/Lys selection (with 
a positively charged C-terminus) would yield stability similar to that of the peptide 1-3-16-7. This is 
partially correct as, regardless of the core arrangement, the E/K cassettes display the highest (Ile/Val) 
or second highest (Leu/Asn) helicities. When observing the Ile/Leu/Val library members, this 
electrostatic arrangement resulted in cassettes with helicities 10-23% higher than the next most 
stable. In the case of Asn, the helicity values are far more similar, with a difference of 10% between 
the four. In this case the polarity of the core Asn appears likely to be influencing the effect that these 
terminal charged residues usually impart upon the macrodipole and therefore upon helicity.  When 
considering the inverse, the lowest helicity cassettes are those with Lys at the N-terminus and Glu at 
the C-terminus. This is logical when considering the arguments proposed previously regarding the 
helix macrodipole within the 29-mer.  
 
CONCLUSION 
We have demonstrated that modular gabcdef heptad cassettes can be lactamised via sidechain to 
sidechain KàD (iài+4) bridges as a mechanism to impart high helicity upon otherwise unstructured 
sequences. We have shown that although all of the sequences adopt helical conformations, the 
fractional helicity observed varies in magnitude from 34 to 68% across the 16 lactamised cassettes. It 
was therefore possible to use the cassettes to create a library that can be conjugated into 4 repeats 
(164 = 65,536 possible combinations) towards creating coiled coil antagonists. Furthermore, we 
utilised the bCIPA library screening algorithm (http://people.bath.ac.uk/jm2219/biology/iscan.zip) as 
a means to select peptides that i) best engage with a heptad counterpart within a target helix and ii) 
have a low tendency to self-associate.  
Conjugating individual cassettes of high measured helicity (1, 3, 16, 7 = 45%, 60%, 55%, 68% 
respectively) into a longer sequence constrained by terminal lactams was shown to impart further 
helicity (fH = 65% linear vs. 71% lactamised), which consequently translated into an increased Tm with 
the cJun target (34°C linear vs 57°C lactamised). In contrast, a control sequence in which component 
cassettes were known to lactamised comparatively poorly (6, 2, 13, 5 = 36%, 34%, 47 %, 41%), was 
lactamised at the termini with only a negligible gain in helicity observed (fH = 18% linear vs. 20% 
lactamised), which translated into only a modest gain in Tm with the cJun target (19°C linear vs 29°C 
lactamised).  
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Since all cassettes exhibited increased helicity when lactamised, this poses an interesting question 
regarding the ability of certain sequences to adopt a more helical conformation than others (Figure 3, 
Figure 9). Since the possible permutations within the 16 peptides were limited, there a limit to the 
information that can be drawn in terms of electrostatic and core configuration that optimise the 
stability of the cassettes. However, the placement of Glu at the N-terminal g position appears to 
impart increased helicity over all other options unless Asn resides at the core a position. The 
placement of Lys at the C-terminal e position appears to be less influential on its own but does 
complement the placement of an N-terminal Glu at the g position. Placement of Lys at the g position 
and Glu at the e position results in the lowest helical values of all cassettes but is tempered slightly by 
the placement of Asn at the a position. With more data, this presents an opportunity to optimise 
computational techniques employed for prediction. As previously shown,22 bCIPA is capable of being 
trained on a specific subset of coiled coil forming sequences. With further experimental exploration 
of the cassette library, reflecting other cassette types observed within natural coiled coils, it will be 
possible to extract more helical predictors towards developing a more robust prediction algorithm 
that can specifically consider lactamised peptides. For instance, further interrogation of the system 
could involve expanding the cassette library to include residues with larger side-chains, or side-chains 
which have been previously shown to be non-optimal at certain sequence positions in the design of 
α-helical peptides. In this study we have probed the ability of given coiled coil sequences to tolerate 
the introduction of KàD lactam bridges between solvent exposed b and f residues. Once established 
that lactams are tolerated then the precise level of helical induction can be calculated. However, the 
assumption that molecules with increasingly higher helicity might better form coiled coils, is an 
oversimplification29,30,33. Rather, there is likely a limit to the entropy value of preorganizing a helical 
structure. Above a certain threshold helicity, conformational entropy may serve to oppose coiled-coil 
formation34, perhaps reflecting the need for some residual helix flexibility to enable the distortion 
necessary for supercoiling35,36.   
The properties of cassettes with high levels of stability in comparison to others will allow 
further understanding of the rules by which bàf lactamisation imparts helicity. As further 
experimental data is acquired, computational techniques employed in the selection of cassettes for 
specific functions will be refined. These “off-the-shelf” sequences can be combined with 
computational screening and applied to a wide range of parallel dimeric coiled coil dimerization 
domains as a generalised method to ablate or even agonise the function of a wide range of proteins 
in which parallel and dimeric coiled coils are found.  
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MATERIALS AND METHODS 
bCIPA Peptide Library Screening - bCIPA screening was performed as described previously22. Briefly, 
individual sequences of cassettes were calculated as homodimers and with the cJun target sequence 
using software based on the bCIPA algorithm28. Thermal denaturation (Tm) values were normalised. 
Peptide Synthesis - Rink amide ChemMatrix™ resin was obtained from PCAS Biomatrix, Inc. (St.-Jean-
sur-Richelieu, Canada); Fmoc L-amino acids and 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetra-
methyluronium hexafluorophosphate (HBTU) or benzotriazol-1-yl-ox-ytripyrrolidinophosphonium 
hexafluorophosphate (PyBOP) were obtained from AGTC Bioproducts (Hessle, UK); all other reagents 
were of peptide synthesis grade and obtained from ThermoFisherScientific (Loughborough,UK). 
Peptides were synthesised on a 0.1-mmol scale on a PCAS ChemMatrix™ Rink amide resin using a 
Liberty Blue™ microwave peptide synthesiser (CEM; Matthews, NC) employing Fmoc solid-phase 
techniques37 with repeated steps of coupling, deprotection and washing (4 × 5 ml 
dimethylformamide).  Coupling was performed as follows: Fmoc amino acid (5 eq), HBTU or PyBOP 
(4.5 eq) and diisopropylethylamine (10 eq) in dimethylformamide (5 ml) for 5 min with 35-W 
microwave irradiation at 90 °C.  Deprotection was performed as follows: 20% piperidine in 
dimethylformamide for 5 min with 30-W microwave irradiation at 80 °C. Following synthesis, peptides 
were acetylated using acetic anhydride (3 eq) and diisopropylethylamine (4.5 eq) in 
dimethylformamide(2.63 ml) for 20 min. Deprotection of acid labile Asp(oPip) and Lys(Mtt) side chain 
protecting groups was achieved by repeated washing of the resin in dichloromethane, followed by 
repeated washes in dichloromenthane (2% TFA), dichloromethane, and finally dimethylformamide. 
Resin was next incubated for 7 hours at 55°C in 2-(1H-benzotriazole-1-yl)-1,1,3,3 tetramethyluronium 
hexafluorophosphate (1ml), diisopropylethylamine (1ml), and dimethylformamide (3ml). Resin was 
filtered and cleaved from the resin with concomitant removal of side-chain-protecting groups by 
treatment with a cleavage mixture (10 ml) consisting of TFA (95%), triisopropylsilane (2.5%) and H2O 
(2.5%) for 4 h at room temperature. Suspended resin was removed by filtration, and the peptide was 
precipitated using three rounds of crashing in ice-cold diethyl ether, vortexing and centrifuging. The 
pellet was then dissolved in 1:1MeCN/H2O and freeze-dried. Purification was performed by RP-HPLC 
using a Phenomenex Jupiter Proteo (C18) reverse-phase column (4 μm, 90 Å, 10 mm inner diameter × 
250 mm long). Eluents used were as follows: 0.1% TFA in H2O (a) and 0.1% TFA in ACN (b). The peptide 
was eluted by applying a linear gradient (at 3.5 ml/min) of 5–95% B over 50 min. Fractions collected 
were examined by electrospray MS, and those found to contain exclusively the desired product were 
pooled and lyophilised. Analysis of the purified final product by RP-HPLC indicated a purity of >95%. 
 
Peptide Quantification – Peptide concentrations were determined in ddH20 or CD buffer (10 mM 
potassium phosphate and 100 mM potassium fluoride, pH 7) against the appropriate blank using the 
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280 nm absorbance maxima of the Tyr residue within each peptide (1209 M-1cm-1). Prior to each 
measurement samples were centrifuged at 13,000 rpm for 2 minutes to ensure that only soluble 
peptide was quantified. During this step no precipitate was observed, indicating that all peptides 
displayed high levels of solubility. Measurements were taken using a Varian Cary 50 Conc UV 
Spectrophotometer using a 1 cm pathlength quartz cell.  
 
Circular Dichroism - CD was carried out using an Applied Photophysics Chirascan CD apparatus 
(Leatherhead, UK) using a 200-μl sample in a CD cell with a 1-mm path length. Samples contained 150 
μM total peptide (Pt) concentration at equimolar concentration for heterodimeric solutions (i.e., 75 
μM per peptide) and suspended in 10 mM potassium phosphate and 100 mM potassium fluoride at 
pH 7 for 30 minutes prior to analysis. The CD spectra of samples were scanned between 300 nm and 
190 nm in 1 nm steps, averaging 0.5 s at each wavelength. Three scans at 20 °C were averaged to 
assess helical levels and CC structure. For thermal scans, spectra were scanned as above in 10°C steps 
from 20°C to 90°C. Each temperature point was held for 1 min to equilibrate sample before scanning.  
Raw data (ellipticities) were collected and averaged, and data were converted to molar residue 
ellipticities (MRE).  
 
All spectral data was converted to fractional helicity (fH) values according to the equation: 
 𝑓𝐻 =	 Ɵ&&& − Ɵ(Ɵ&&&) − Ɵ( Ɵ( = 	2220	 −	(53 × 𝑇) Ɵ&&&) = (−44000 + (250 × 𝑘)) 		× 	(1	 − 𝑘𝑁𝑟	) 
 
Where the wavelength-dependent constant k = 2.4 (at 222nm), Nr = number of residues, and T = 
temperature (°C). 
 
Thermal Denaturation – Thermal denaturation experiments were performed at 150 μM in a buffer of 
10 mM potassium phosphate and 100 mM potassium fluoride at pH 7 using an Applied Photophysics 
Chirascan Circular Dichroism Spectrometer. For all thermal denaturation experiments involving longer 
peptides, a stepping gradient was applied from 0°C to 90°C using 1°C increments. Each temperature 
point was held for 30 seconds to equilibrate the sample before measuring ellipticity at 222 nm. Melting 
profiles were converted to equilibrium denaturation curves and fitted using a two-state model, 
derived via modification of the Gibbs–Helmholtz equation to yield the melting temperature (Tm)28. 
 
(1) 
 13 
AUTHOR CONTRIBUTIONS  
AL conducted experiments, and synthesized, purified and characterised peptides and cJun. JMM 
directed the research. Both authors participated in experimental design, analysis of the data, and 
writing the paper.  
 
COMPETING FINANTIAL INTERESTS 
JMM is an advisor to Sapience Therapeutics. AL has no financial or commercial conflict to declare. 
 
ACKNOWLEDGEMENTS  
J.M. and A.L thank the University of Bath for a Studentship. J.M. is also grateful to Cancer Research UK 
(A11738 and A26941) and to the BBSRC (BB/R017956/1) and EPSRC (EP/M001873/1).  
 
SUPPORTING INFORMATION 
Supporting information is available in Supplementary Figures S1-S8 and Supplementary Tables S1-S2 
with associated legends online. This material is available free of charge via the internet 
at http://pubs.acs.org.  
 
 
REFERENCES 
(1) Walensky, L. D., and Bird, G. H. (2015) Hydrocarbon-Stapled Peptides: Principles, Practice, and 
Progress. J. Med. Chem. 57, 6275–6288. 
(2) De Araujo, A. D., Hoang, H. N., Kok, W. M., Diness, F., Gupta, P., Hill, T. A., Driver, R. W., Price, D. 
A., Liras, S., Fairlie, D. P., de Araujo, A. D., Hoang, H. N., Kok, W. M., Diness, F., Gupta, P., Hill, T. A., 
Driver, R. W., Price, D. A., Liras, S., and Fairlie, D. P. (2014) Comparative α-helicity of cyclic 
pentapeptides in water. Angew. Chemie - Int. Ed. 53, 6965–6969. 
(3) Acharyya, A., Ge, Y., Wu, H., DeGrado, W. F., Voelz, V. A., and Gai, F. (2019) Exposing the Nucleation 
Site in α-Helix Folding: A Joint Experimental and Simulation Study. J. Phys. Chem. B acs.jpcb.8b12220. 
(4) Hilinski, G. J. (2012) Stapled Peptides for Intracellular Drug Targets. Methods Enzymol. 503, 3–33. 
(5) Tan, Y. S., Lane, D. P., and Verma, C. S. (2016) Stapled peptide design: principles and roles of 
computation. Drug Discov. Today 21, 1642–1653. 
(6) Pal, S., and Prabhakaran, E. N. (2018) Hydrogen bond surrogate stabilized water soluble 310-helix 
from a disordered pentapeptide containing coded α-amino acids. Tetrahedron Lett. 59, 2515–2519. 
(7) Patgiri, A., Jochim, A. L., and Arora, P. S. (2008) A Hydrogen Bond Surrogate Approach for 
Stabilization of Short Peptide Sequences in α-Helical Conformation. Acc. Chem. Res. 41, 1289–1300. 
(8) Estieu-Gionnet, K., and Guichard, G. (2011) Stabilized helical peptides: overview of the technologies 
 14 
and therapeutic promises. Expert Opin. Drug Discov. 6, 937–963. 
(9) Lau, Y. H., De Andrade, P., Wu, Y., and Spring, D. R. (2015) Peptide stapling techniques based on 
different macrocyclisation chemistries. Chem. Soc. Rev. 44, 91–102. 
(10) Pelay-Gimeno, M., Glas, A., Koch, O., and Grossmann, T. N. (2015) Structure-Based Design of 
Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes. Angew. Chemie - Int. 
Ed. 54, 8896–8927. 
(11) Shepherd, N. E., Hoang, H. N., Abbenante, G., and Fairlie, D. P. (2005) Single turn peptide alpha 
helices with exceptional stability in water. J. Am. Chem. Soc. 127, 2974–2983. 
(12) Shepherd, N. E., Abbenante, G., and Fairlie, D. P. (2004) Consecutive cyclic pentapeptide modules 
form short alpha-helices that are very stable to water and denaturants. Angew. Chemie - Int. Ed. 43, 
2687–2690. 
(13) Tala, S. R., Schnell, S. M., and Haskell-Luevano, C. (2015) Microwave-assisted solid-phase synthesis 
of side-chain to side-chain lactam-bridge cyclic peptides. Bioorganic Med. Chem. Lett. 25, 5708–5711. 
(14) Harrison, R. S., Shepherd, N. E., Hoang, H. N., Ruiz-Gomez, G., Hill, T. A., Driver, R. W., Desai, V. S., 
Young, P. R., Abbenante, G., and Fairlie, D. P. (2010) Downsizing human, bacterial, and viral proteins 
to short water-stable alpha helices that maintain biological potency. Proc. Natl. Acad. Sci. 107, 11686–
11691. 
(15) Hoang, H. N., Driver, R. W., Beyer, R. L., Hill, T. A., D. de Araujo, A., Plisson, F., Harrison, R. S., 
Goedecke, L., Shepherd, N. E., and Fairlie, D. P. (2016) Helix Nucleation by the Smallest Known α-Helix 
in Water. Angew. Chemie - Int. Ed. 55, 8275–8279. 
(16) Hoang, H. N., Song, K., Hill, T. A., Derksen, D. R., Edmonds, D. J., Kok, W. M., Limberakis, C., Liras, 
S., Loria, P. M., Mascitti, V., Mathiowetz, A. M., Mitchell, J. M., Piotrowski, D. W., Price, D. A., Stanton, 
R. V., Suen, J. Y., Withka, J. M., Griffith, D. A., and Fairlie, D. P. (2015) Short hydrophobic peptides with 
cyclic constraints are potent glucagon-like peptide-1 receptor (GLP-1R) agonists. J. Med. Chem. 58, 
4080–4085. 
(17) Seebach, D., and Fadel, A. (1985) N,O-Acetals from Pivalaldehyde and Amino Acids for the ?-
Alkylation with Self-Reproduction of the Center of Chirality. Enolates of 3-Benzoyl-2-(tert-butyl)-1,3-
oxazolidin-5-ones. Helv. Chim. Acta 68, 1243–1250. 
(18) Mason, J. M., Schmitz, M. A., Muller, K. M., and Arndt, K. M. (2006) Semirational design of Jun-
Fos coiled coils with increased affinity: Universal implications for leucine zipper prediction and design. 
Proc. Natl. Acad. Sci. 103, 8989–8994. 
(19) Hagemann, U. B., Mason, J. M., Müller, K. M., and Arndt, K. M. (2008) Selectional and Mutational 
Scope of Peptides Sequestering the Jun-Fos Coiled-Coil Domain. J. Mol. Biol. 381, 73–88. 
(20) Crooks, R. O., Baxter, D., Panek, A. S., Lubben, A. T., and Mason, J. M. (2016) Deriving 
Heterospecific Self-Assembling Protein-Protein Interactions Using a Computational Interactome 
 15 
Screen. J. Mol. Biol. 428, 385–398. 
(21) Crooks, R. O., Lathbridge, A., Panek, A. S., and Mason, J. M. (2017) Computational Prediction and 
Design for Creating Iteratively Larger Heterospecific Coiled Coil Sets. Biochemistry 56, 1573–1584. 
(22) Lathbridge, A., and Mason, J. M. (2018) Computational Competitive and Negative Design to Derive 
a Specific cJun Antagonist. Biochemistry 57, 6108–6118. 
(23) Hill, T. A., Shepherd, N. E., Diness, F., and Fairlie, D. P. (2014) Constraining cyclic peptides to mimic 
protein structure motifs. Angew. Chemie - Int. Ed. 53, 13020–13041. 
(24) Mason, J. M., Müller, K. M., and Arndt, K. M. (2007) Positive aspects of negative design: 
Simultaneous selection of specificity and interaction stability. Biochemistry 46, 4804–4814. 
(25) Mason, J. M., Müller, K. M., and Arndt, K. M. (2007) Considerations in the design and optimization 
of coiled coil structures., in Methods in molecular biology (Clifton, N.J.), pp 35–70. Springer. 
(26) Mason, J. M., and Arndt, K. M. (2004) Coiled coil domains: Stability, specificity, and biological 
implications. ChemBioChem 5, 170–176. 
(27) Fletcher, J. M., Bartlett, G. J., Boyle, A. L., Danon, J. J., Rush, L. E., Lupas, A. N., and Woolfson, D. 
N. (2017) N@ a and N@ d: Oligomer and Partner Specification by Asparagine in Coiled-Coil Interfaces. 
ACS Chem. Biol. 12, 528–538. 
(28) Mason, J. M., Hagemann, U. B., and Arndt, K. M. (2007) Improved stability of the Jun-Fos activator 
protein-1 coiled coil motif: A stopped-flow circular dichroism kinetic analysis. J. Biol. Chem. 282, 
23015–23024. 
(29) Baxter, D., Perry, S. R., Hill, T. A., Kok, W. M., Zaccai, N. R., Brady, R. L., Fairlie, D. P., and Mason, 
J. M. (2017) Downsizing Proto-oncogene cFos to Short Helix-Constrained Peptides That Bind Jun. ACS 
Chem. Biol. 12, 2051–2061. 
(30) Rao, T., Ruiz-Gómez, G., Hill, T. A., Hoang, H. N., Fairlie, D. P., and Mason, J. M. (2013) Truncated 
and Helix-Constrained Peptides with High Affinity and Specificity for the cFos Coiled-Coil of AP-1. PLoS 
One (Sanchez-Ruiz, J. M., Ed.) 8, e59415. 
(31) Ganesan, S. J., and Matysiak, S. (2014) Role of Backbone Dipole Interactions in the Formation of 
Secondary and Supersecondary Structures of Proteins. 
(32) Aurora, R., and Rosee, G. D. (1998) Helix capping. Protein Sci. 7, 21–38. 
(33) Dragan, A. I., and Privalov, P. L. (2002) Unfolding of a Leucine zipper is not a Simple Two-state 
Transition. J. Mol. Biol. 321, 891–908. 
(34) Worrall, J. A. R., and Mason, J. M. (2011) Thermodynamic analysis of Jun-Fos coiled coil peptide 
antagonists. FEBS J. 278, 663–672. 
(35) Crick, F. H. C. (1953) The packing of α-helices: simple coiled-coils. Acta Crystallogr., pp 689–697. 
International Union of Crystallography (IUCr). 
(36) Pauling, L., Corey, R. B., and Branson, H. R. (1951) The structure of proteins; two hydrogen-bonded 
 16 
helical configurations of the polypeptide chain. Proc. Natl. Acad. Sci. U. S. A. 37, 205–11. 
(37) Fields, G. B., and Noble, R. L. (1990) Solid phase peptide synthesis utilizing 9-
fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35, 161–214. 
 
 
Figure Legends: 
 
Figure 1. Design of heptad cassette sequences. Peptide options are randomised around electrostatic 
positions g and e (Glu/Lys) and core position a (Ile/Leu/Val/Asn). This illustrates the diverse options 
available at the hydrophobic interface and the different charge profiles available for electrostatic 
interactions. The lactam bridge between b-f (Lys-to-Asp) is also shown. 
 
Figure 2. CD spectra for cassettes 1-16. These are shown in both the linear (black) and lactamised 
(red) forms. Spectra were measured at 20 °C at a total peptide concentration of 150 μM and presented 
as mean residue ellipticity (MRE). All experiments were performed in 10 mM potassium phosphate 
and 100 mM potassium fluoride (pH 7). In all cases, the linear forms were characterised as having a 
random coil profile – with an average 222 nm/208 nm ratio of 0.24. The lactamised cassettes displayed 
more of a helical profile – with an average ratio of the signal at 222 nm/208 nm of 0.79. 
 
Figure 3. Fractional helicity (fH) data for Cassettes 1-16. (A) shows values calculated from the 222 nm 
value from circular dichroism scans at 20°C. For each cassette, the cyclic (lactamised) form has 
increased helicity compared to the linear (black), with an average increase of 37.6%. The ΔfH values 
(B) show that the largest increase in helicity was seen in Cassette 16 (ΔfH = 50.63%) whereas the 
lowest increase in helicity was seen in Cassette 8 (ΔfH = 22.57%). Highlighted are the cassettes used 
in the full-length peptide (*) and those used in the control (+). 
 
Figure 4. Design of lactamised sequences.  Shown are 1-3-16-7 (A) and control 6-2-13-5 (B). In both 
cases cassettes were chosen independently of one another. For 1-3-16-7, considering the cassettes in 
isolation, there is a mixture of electrostatically repulsive (cassette 1), favourable (cassette 3), and non-
optimal (cassette 16). For heptad 3 (C), the Asn-Asn interaction has been selected for at the core. For 
6-2-13-5 there is a mixture of electrostatically favourable (cassette 6), partially favourable (cassettes 
2,5), and non-optimal (cassette 13). For heptad 3 (C), the Asn-Asn interaction has been selected for at 
the core. C: Sequences for peptides 1-3-16-7 and 6-2-13-5. The addition of a Tyr at the N-terminus 
creates a 29 residue peptide that starts at the f position and ends at the f position. Highlighted in green 
are the cassettes which have Lys/Asp lactamisation (1 and 7 / 6 and 5). 
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Figure 5. CD spectra and thermal denaturation data for linear and lactamised peptides in isolation. 
Shown are data for 1-3-16-7 (A and C) and 6-2-13-5 (B and D). Spectra were measured at 20 °C at a 
total peptide concentration of 150 μM and presented as mean residue ellipticity (MRE). The minima 
at 208 and 222 nm are indicative of a helical structure, with the 222 nm/208 nm ratio of the lactamised 
1-3-16-7 showing more structure (222 nm/208 nm = 1.01) than the linear (222 nm/208 nm = 0.89). 
The lactamised 6-2-13-5 shows increased helical structure (222 nm/208 nm =0.69) compared to the 
linear (222 nm/208 nm =0.44) This suggests that the addition of lactam bridges improves the α-helicity 
in both peptides. Thermal denaturation profiles of linear and lactamised 1-3-16-7 (C) and 6-2-13-5(D) 
peptides were taken using 1°C increments and tracking the 222 nm signal at 150 μM. Lactamised 1-3-
16-7 shows an increase in the transition midpoint with a Tm of 67.0°C compared to the linear Tm of 
29.1°C. Lactamised 6-2-13-5 demonstrates a change* in the transition midpoint when in complex with 
cJun compared to the linear*. All experiments were performed in 10 mM potassium phosphate and 
100 mM potassium fluoride (pH 7). Where possible (C), data were fitted to the two-state model.  
 
Figure 6. CD spectra and thermal denaturation data for linear and lactamised 1-3-16-7 with cJun. 
Shown are data for 1-3-16-7 peptide in the linear (A and C) and lactamised (B and D) in complex with 
cJun. Spectra were measured at 20 °C at a total peptide concentration of 150 μM and presented as 
mean residue ellipticity (MRE). The minima at 208 and 222 nm are indicative of a helical structure, 
with the 222 nm/208 nm ratio of the linear peptide with cJun showing similar structure (222 nm/208 
nm = 0.87) to the homomeric complex (222 nm/208 nm = 0.89). The lactamised form displays a 
decreased helical structure (222 nm/208 nm =0.90) compared to homomeric state (222 nm/208 nm 
=1.01). Thermal denaturation profiles of homomeric 1-3-16-7 and in complex with cJun (C and D) were 
measured using 1°C increments and tracking the 222 nm signal at 150 μM. Linear 1-3-16-7 displays an 
increase in the transition midpoint when in complex with cJun (C), with a Tm of 34°C compared to the 
homomer (Tm = 29.1°C). Lactamised 1-3-16-7 demonstrates a decrease in the transition midpoint, 
with a Tm value of 57.2°C when in complex with cJun compared to the homomer Tm of 67°C (cJun Tm 
= 25.8°C). All experiments were performed in 10 mM potassium phosphate and 100 mM potassium 
fluoride (pH 7). Where possible (D), data were fitted to the two-state model. 
 
Figure 7. CD spectra and thermal denaturation data for linear and lactamsied 6-2-13-5 with cJun. 
Shown are data for 6-2-13-5 peptide in the linear (A and C) and lactamised (B and D) in complex with 
cJun. Spectra were measured at 20 °C at a total peptide concentration of 150 μM and presented as 
mean residue ellipticity (MRE). The minima at 208 and 222 nm are indicative of various levels of helical 
structure, with the 222 nm/208 nm ratio of the linear peptide with cJun showing increased structure 
(222 nm/208 nm = 0.60) to the homomeric complex (222 nm/208 nm = 0.44). The lactamised form 
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shows increased structure (222 nm/208 nm =0.74) compared to homomeric state (222 nm/208 nm 
=0.69). This implies that the addition of cJun increased the helicity of the lactamised and linear 
peptide. Thermal denaturation profiles of homomeric 6-2-13-5 and in complex with cJun (C and D) 
were taken using 1°C increments and tracking the 222 nm signal at 150 μM. Linear 6-2-13-5 shows an 
increase in the transition midpoint when in complex with cJun (C), demonstrating a Tm of 18.9°C 
compared to the homomer*. Lactamised 6-2-13-5 demonstrates an in the transition midpoint, with a 
Tm value of 25.0°C when in complex with cJun compared to the homomer*. All experiments were 
performed in 10 mM potassium phosphate and 100 mM potassium fluoride (pH 7). Where possible 
(D), data were fitted to the two-state model . *Denaturation profiles for homomeric 6-2-13-5 (linear 
and lactamised) were unable to be fit. 
 
Figure 8. A comparison of the full-length peptides. The Tm of lactamised 1-3-16-7 was 71.4°C as a 
homomer and 57.2°C in complex with cJun. x indicates an inability to determine a Tm from the melt 
profile and represents a low stability complex. 
 
Figure 9. Analysis of individual cassette composition demonstrates stability to be sequence specific. 
Across the library, a Lys/Glu combination at positions g/e result in decreased helicity. Conversely, the 
selection of Glu/Lys at these positions results in higher levels of helicity – with a delta of 10-23% 
between cassettes 7/9/11 and the next most stable cassettes. Asn containing cassettes exhibited 
similar patterns, although the differences between helicity values within the 4 cassettes was shown 
to be minimal (a delta of 10% within C13-16). 
 
Table 1. The Comparative Helicity of Cassettes 1-16. Sequences for Cassettes 1-16 are shown with 
linear and cyclic fH values (and the difference) as determined by circular dichroism at 20°C. Cassettes 
with the highest (red) and lowest (blue) cyclic fH values are highlighted. 
 
Table 2. Selection of Cassettes For Conjugation. Heptads 1-4 of cJun (shown in red) have been 
predicted against each of the cassettes, alongside the helicity of the lactamised forms from circular 
dichroism. The bCIPA heterodimer values (cassette – cJun) have been normalised to account for all 
values <0. Highlighted in green are the cassettes chosen for the full-length alpha helix. Highlighted in 
yellow are the cassettes chosen for the full-length control peptide, chosen by the predicted Tm alone. 
For heptad 3, the only cassettes considered were 13-16 (since they contain Asn at the a position). 
Cassettes were chosen sequentially, and no cassette was selected multiple times. In total 164 cassette 
combinations were possible leading to 65,536 potential peptide sequences.  
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Figure 9
Cassette 
Number
Sequence
gabcdef
gaKALeD
Linear fH (%) Cyclic fH (%) ΔfH(%)
1 (Y)EIKALED 10.8 45.0 34.2
2 (Y)KIKALED 10.8 34.4 23.5
3 (Y)ELKALED 10.4 60.3 49.9
4 (Y)KLKALED 4.1 35.3 31.2
5 (Y)EVKALED 9.3 41.4 32.1
6 (Y)KVKALED 7.9 35.9 28.0
7 (Y)EIKALKD 17.6 67.5 49.9
8 (Y)KIKALKD 18.6 41.1 22.6
9 (Y)ELKALKD 14.8 57.0 42.2
10 (Y)KLKALKD 6.2 47.4 41.2
11 (Y)EVKALKD 12.6 62.2 49.6
12 (Y)KVKALKD 8.0 48.7 40.7
13 (Y)ENKALED 14.7 46.7 32.0
14 (Y)KNKALED 7.4 44.8 37.4
15 (Y)ENKALKD 12.4 49.1 36.7
16 (Y)KNKALKD 4.5 55.1 50.6
Table 1. The Comparative Helicity of Cassettes 1-16
RIARLEE KVKTLKA QNYELAS TANMLRE 
Heptad 1 Heptad 2 Heptad 3 Heptad 4
Cassette Heterodimer Tm ( °C)
Helicity 
(%) Cassette
Heterodimer 
Tm ( °C)
Helicity 
(%) Cassette
Heterodimer 
Tm ( °C)
Helicity 
(%) Cassette
Heterodimer 
Tm ( °C)
Helicity 
(%)
2 31.1 34.4% 1 47.2 45.0% 1 12.5 45.0% 3 27.6 60.3%
6 29.8 35.9% 3 44.8 60.3% 7 10.7 67.5% 1 24.7 45.0%
4 28.7 35.3% 5 40.6 41.4% 3 10.2 60.3% 5 23.4 41.4%
1 25.8 45.0% 2 33.4 34.4% 13 8.7 46.7% 9 23.4 57.0%
5 24.5 41.4% 7 33.4 67.5% 9 8.4 57.0% 7 20.5 67.5%
3 23.4 60.3% 4 31.0 35.3% 2 8.4 34.4% 11 19.2 62.2%
8 19.8 41.1% 9 31.0 57.0% 15 6.9 49.1% 4 16.2 35.3%
12 18.5 48.7% 13 27.5 46.7% 8 6.6 41.1% 13 15.5 46.7%
10 17.4 47.4% 11 26.9 62.2% 4 6.0 35.3% 2 13.3 34.4%
14 16.7 44.8% 6 26.9 35.9% 5 6.0 41.4% 10 12.0 47.4%
7 14.4 67.5% 8 19.7 41.1% 14 4.5 44.8% 6 12.0 35.9%
11 13.1 62.2% 10 17.3 47.4% 10 4.2 47.4% 15 11.3 49.1%
9 12.0 57.0% 14 13.7 44.8% 11 4.2 62.2% 8 9.1 41.1%
13 11.3 46.7% 15 13.7 49.1% 16 2.7 55.1% 12 7.8 48.7%
16 5.4 55.1% 12 13.1 48.7% 6 1.8 35.9% 14 4.2 44.8%
15 0.0 49.1% 16 0.0 55.1% 12 0.0 48.7% 16 0.0 55.1%
Table 2. Selection of Cassettes For Conjugation
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Supporting Information 
Electrospray Mass Spectroscopy Data of Linear and Lactamised Peptides – All 32 peptides provided 
an excellent agreement between the expected and observed mass in both linear and lactamised 
versions of peptide (Figure S1, peptides 1-4; Figure S2, Peptides 5-8; Figure S3, peptides 9-12; Figure 
S4, peptides 13-16).  
 
Peptide Sequences - All synthesised and characterised peptides were amidated and acetylated. 
cJun:     ASRIARLEEKVKTLKAQNYELASTANMLREQVAQLKGAP 
1-3-16-7: YEIKALEDELKALEDKNKALKDEIKALKD 
6-2-13-5: YKVKALEDKIKALEDENKALEDEVKALED 
 
Sequence Specificity - All cassettes exhibited an increase in helicity when lactamised. However, the 
extent of helical gain varied, with the ability of certain residues to tolerate lactamisation over others 
being less clear (Fig S5-S6). As shown in Figure 3b, a wide range of fH increase due to lactamisation 
was observed. Since the possible amino acids combinations at a/e/g positions were limited, only 
partial interpretations can be drawn from the electrostatic and core configurations in optimising 
cassette stability. This does however present an opportunity to optimise the computational 
techniques employed. As previously shown,1 bCIPA is capable of being trained on a specific subset of 
coiled coil forming sequences. With further experimental exploration of the cassette library, it may be 
possible to extract the predictors and develop a more specific prediction algorithm for this use. 
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Conjugated Peptide Lactamisation - As shown in Figures S7 and S8, both of the peptides exhibited a 
decrease in mass of 36 Da, indicating that both lactam bridges successfully formed between Asp and 
Lys, resulting in the loss of two water molecules.  
 
Although peptides truncated less than 29 residues have been explored previously2–7 with a focus on 
maintaining stability, it was decided to conjugate four cassettes to maximise the potential 
interpretation and to maintain a quantifiable stability with the target.  
 
Table S1. Electrospray Mass Spectroscopy Data of Linear and Lactamised Peptides 
Peptide Sequence 
Expected  
Linear Mass  
Observed 
Linear Mass  
Expected 
Cyclic Mass 
Observed 
Cyclic Mass  
Mass Change 
Linear — Cyclic 
1 YEIKALED 1021.50 1021.53 1003.50 1003.52 18.01 
2 YKIKALED 1020.55 1020.58 1002.55 1002.57 18.01 
3 YELKALED 1021.50 1021.53 1003.50 1003.53 18.00 
4 YKLKALED 1021.50 1020.58 1003.50 1002.57 18.01 
5 YEVKALED 1007.48 1007.51 989.48 989.51 18.00 
6 YKVKALED 1006.53 1006.56 988.53 988.56 18.00 
7 YEIKALKD 1020.55 1020.57 1002.55 1002.57 18.00 
8 YKIKALKD 1019.60 1019.62 1001.60 1001.62 18.00 
9 YELKALKD 1020.55 1020.58 1002.55 1002.57 18.01 
10 YKLKALKD 1019.60 1019.62 1001.60 1001.62 18.01 
11 YEVKALKD 1006.53 1006.57 988.53 988.55 18.01 
12 YKVKALKD 1005.59 1005.61 987.59 987.61 18.01 
13 YENKALED 1022.46 1022.48 1004.46 1004.48 18.00 
14 YKNKALED 1021.51 1021.53 1003.51 1003.52 18.01 
15 YENKALKD 1021.51 1021.53 1003.51 1003.53 18.01 
16 YKNKALKD 1020.56 1020.59 1002.56 1002.58 18.01 
 
Mass spectrometry data for cassettes 1-16. For each peptide the predicted mass, observed mass for both linear and cyclic 
forms of each cassette are shown. As expected, the difference between the linear and lactamised form of the cassette 
accounts for the loss of one water molecule in every case. 
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Table S2. Helical and Thermal Stability of Linear and Lactamised Peptides 
Computational Processing 
All software was run on Python on a 64-bit x64-based processor Windows machine with 12 GB of RAM 
as described previously1.  
 
Figure S1. Electrospray Mass Spectrometry data from the purified cassettes 1-4 demonstrating a loss 
of 18 Da between the linear and successfully lactamised forms of cassette 1 (A/B), cassette 2 (C/D), 
cassette 3 (E/F), and cassette 4 (G/H). 
 
Figure S2. Electrospray Mass Spectrometry data from the purified cassettes 5-8 demonstrating a loss 
of 18 Da between the linear and successfully lactamised forms of cassette 5 (A/B), cassette 6 (C/D), 
cassette 7 (E/F), and cassette 8 (G/H). 
 
Figure S3. Electrospray Mass Spectrometry data from the purified cassettes 9-12 demonstrating a 
loss of 18 Da between the linear and successfully lactamised forms of cassette 9 (A/B), cassette 10 
(C/D), cassette 11 (E/F), and cassette 12 (G/H). 
 
Figure S4. Electrospray Mass Spectrometry data from the purified cassettes 13-16 demonstrating a 
loss of 18 Da between the linear and successfully lactamised forms of cassette 13 (A/B), cassette 14 
(C/D), cassette 15 (E/F), and cassette 16 (G/H). 
 
Figure S5. Thermal spectra for cassettes 1-16 in linear form. Spectra were initially measured at 20 °C 
(black) and in 10°C increments to 90°C (red) and then post melt at 20°C (blue) at a total peptide 
concentration of 150 μM and presented as mean residue ellipticity (MRE).  All experiments were 
performed in 10 mM potassium phosphate and 100 mM potassium fluoride (pH 7). For all cases, the 
A comparison of the full length peptide complexes – with their fractional helicty, 222 nm/208 nm ratio, and transition 
midpoint (Tm) values.  
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linear forms were characterised as having a random coil profile at 20°C, both prior to thermal 
denaturation and  as post-melt samples, with disorder persisting at 90°C.  
 
Figure S6. Thermal spectra for cassettes 1-16 in lactamised form. Spectra were initially measured at 
20 °C (black) and in 10°C increments to 90°C (red) and then post melt at 20°C (blue) at a total peptide 
concentration of 150 μM and presented as mean residue ellipticity (MRE).  All experiments were 
performed in 10 mM potassium phosphate and 100 mM potassium fluoride (pH 7). In all cases, 
lactamised cassettes presented as α-helical at 20°C and returned to within 5% of the same helical 
signature as post-melt samples, with an average helicity of 48%. Consistent with lactamisation as a 
potent helix-inducer, at 90°C helicity was retained with an average fH of 38%.  
 
Figure S7. Electrospray Mass Spectrometry data from the purified full-length 1-3-16-7 demonstrates 
the peptide to have the expected mass of 3415.91 Da as a linear sequence (A) and the expected mass  
of 3379.91 Da when lactamised (B). The loss of 36 Da demonstrates that there has been successful 
successful lactamisation at both termini consistent with the loss of two water molecules. 
 
Figure S8. Electrospray Mass Spectrometry data from the purified full-length 6-2-13-5 demonstrates 
the peptide to have the expected mass of 3388.79 Da as a linear sequence (A) and the expected mass 
of 3352.79 Da when lactamised (B). The loss of 36 Da demonstrates that there has been successful 
lactamisation at both termini consistent with the loss of two water molecules. 
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